![](\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2026\/01\/Dj-Muggs-3.jpeg\")
<\/p>\n <\/p>\n
In a chandelier-lit ballroom at Berlin\u2019s Hotel Adlon Kempinski, a quiet revolution is unfolding. Dozens of investors lean in as founders from Zurich, Barcelona, Lisbon and Warsaw pitch a room full of international cannabis investors and the CEOs of the EU\u2019s next cannabis giants. This is a Talman House event, and it\u2019s where European cannabis capital finds its match.<\/p>\n
After years of uneven reform, Europe\u2019s cannabis market is finally entering its investment era. As North America wrestles with oversupply and political fatigue, European operators are drawing global attention to their pharmaceutical precision, export potential and growing regulatory stability.<\/p>\n
From Albania to Spain and everywhere in between, governments are expanding medical cannabis access and homegrow rights in various forms. In Germany, the new conservative CDU government is cautious on cannabis, but indications suggest they\u2019ll still advance adult-use legalization. Personal possession of up to 25 grams is allowed in public in Germany. Meanwhile, medical supply chains are growing across Western and Eastern Europe through controlled licensing and pilot programs.<\/p>\n
Europe remains a frontier defined by both opportunity and red tape. Many deals favor convertible debt or structured instruments over pure equity. Despite the cautiousness, institutional interest is rising. Germany\u2019s Demecan, for example, recently hit a \u20ac100 million valuation backed partly by US investors. Last September, Canada\u2019s High Tide purchased a 51 percent interest in cannabis pharma operator Remexian AG with an option to pick up the other 49 percent. Europe\u2019s cannabis infrastructure is maturing and investors are watching closely.<\/p>\n
With most national markets still small in scale, the long-term play centers on trading internationally. Companies are positioning themselves to supply EU GMP-certified cannabis and cannabinoid-based pharmaceuticals across the region. While the legal framework is evolving, transparent governance and robust due diligence are non-negotiable for investors. Recent scandals like the collapse of the JuicyFields Ponzi scheme have left many wary. \u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n
Among the new generation of European investment platforms, The Talman Group<\/a> stands out as a credible, selective, membership-based network connecting cannabis and cannabis-adjacent companies with global investors. Its model blends exclusive events in prestigious venues with curated deal sourcing and introductions to sophisticated investors who want compliant and investable opportunities.<\/p>\n In April 2025, Talman hosted more than 140 participants at the Adlon Kempinski in Berlin, where a handful of highly curated companies pitched to investors in a Shark Tank-style setting. As the investment arm of Europe\u2019s largest B2B conference and expo, International Cannabis Business Conference (ICBC), Talman lends a layer of legitimacy to an industry still working to shake its early growing pains in the adolescence of Europe\u2019s cannabis industry.<\/p>\n Talman serves as a figurative mentor guiding Europe\u2019s cannabis industry toward maturity. Its role extends beyond matchmaking. The platform provides a buffer of due diligence by screening decks, tracking market intelligence and connecting founders to legal, financial and strategic advisors. Creating the conditions for credible, sustainable industry growth, Talman\u2019s curated network brings much-needed capital into reach for operators bridging a capital desert.<\/p>\n And the opportunity is real in these undercapitalized European markets. Early entrants can enjoy \u201cfirst mover\u201d status, and if they utilize the head start efficiently, can parlay that into market leadership and delight their investors. Additionally, success in one jurisdiction often opens doors across the EU\u2019s emerging regulatory patchwork. The evolution of policies in Germany, the Netherlands and the United Kingdom could provide compliant, scaled operators with significant upside.<\/p>\n All that said, uncertainty due to evolving regulations continues. Pilot programs have faced repeated delays in the Netherlands and Switzerland. Shallow public markets limit exits, and scandals and bankruptcies remind investors that gaps in oversight can be costly.<\/p>\n Big conglomerates such as British American Tobacco and Tilray entering the space raise the bar for smaller firms as well. Investors have witnessed how market exuberance can outpace fundamentals, but greed is a powerful blinder. Valuation discipline will be essential. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n Europe\u2019s cannabis story is unfolding in distinct phases. There are policy harmonization efforts across EU member states, with standardized licensing and quality controls being considered. Simultaneously, cross-border consolidation through multi-country acquisitions and partnerships is already underway. Expect consolidation to pick up speed in 2026 as more North American companies consider Europe\u2019s potential. As the cycle matures, institutional investors will participate by having pension and health funds make cautious allocations. That typically triggers financial innovation (e.g. REITs and special-purpose investment vehicles). Lastly, as compliance standards mature, de-risking through transparency becomes the norm.<\/p>\n Europe\u2019s cannabis investment story isn\u2019t about chasing another green rush. It\u2019s about building the infrastructure that makes the rush possible. Platforms like the Talman Group are helping investors see Europe not as 27 fragmented markets, but as one evolving opportunity. For those willing to navigate complexity, the reward may be as lasting as the reform itself.<\/p>\n This story was originally published in issue 52 of the\u00a0print edition<\/a>\u00a0of Cannabis Now.<\/em><\/p>\n The post Europe\u2019s Cannabis Market Is (Finally) Growing Up<\/a> appeared first on Cannabis Now<\/a>.<\/p>\n
In a chandelier-lit ballroom at Berlin\u2019s Hotel Adlon Kempinski, a quiet revolution is unfolding. Dozens of investors lean in as founders from Zurich, Barcelona, Lisbon and Warsaw pitch a room full of international cannabis investors and the CEOs of the EU\u2019s next cannabis giants. This is a Talman House event,Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":580,"featured_media":85173,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[50,3882,170,490,137,85,69,17374,57,19701,19702],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85172"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/580"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=85172"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85172\/revisions"}],"predecessor-version":[{"id":85174,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/85172\/revisions\/85174"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media\/85173"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=85172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=85172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=85172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/a>
\n
\nRead More: Europe\u2019s Cannabis Market Is (Finally) Growing Up<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"